Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00360191 · ClinicalTrials.gov registry record · Phase 2
A Placebo-Controlled Trial of Buspirone for Treatment of Marijuana Dependence
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 81
- Enrollment target
NCT00360191 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 81 participants.
The verdict
NCT00360191, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 81 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if buspirone combined with motivational enhancement therapy is effective in reducing marijuana use in marijuana-dependent adults.
Interventions
- DRUG Buspirone
- PROCEDURE Motivational enhancement therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2004-04 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00360191
The ClinicalTrials.gov registry entry for NCT00360191 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Buspirone is the first listed.
NCT00360191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00360191 about?
NCT00360191 is a clinical study titled "A Placebo-Controlled Trial of Buspirone for Treatment of Marijuana Dependence". The purpose of this study is to determine if buspirone combined with motivational enhancement therapy is effective in reducing marijuana use in marijuana-dependent adults.
What is the current status of trial NCT00360191?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 81 participants. The study started on 2004-04. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00360191?
The interventions under investigation include: Buspirone (DRUG), Motivational enhancement therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00360191?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.